Search clinical trials for: Neurokinin-1 Receptor Antagonists

Total 11461 results

Fifth Affiliated Hospital, Sun Yat-Sen University
Third Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Nighttime Valsartan in Hemodialysis Hypertension (NVHH)

Hypertension;Nephropathy
Emory University
National Institute on Aging (NIA)

Completed

Candesartan's Effects on Alzheimer's Disease And Related Biomarkers (CEDAR)

Mild Cognitive Impairment

United States
Children's Hospital Medical Center, Cincinnati

Completed

Losartan to Reverse Sickle Nephropathy

Sickle Cell Anemia | Nephropathy

United States
Takeda

Completed

International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

Hypertension

Russian Federation, Kazakhstan
Takeda

Completed

Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

Type 2 Diabetes Mellitus | Essential Hypertension

Taiwan, Thailand, China
Wake Forest University Health Sciences
Johns Hopkins University

Terminated

Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients (RAS-HIV)

HIV | Sarcopenia | Aging | Angiotensin Receptor Antagonists

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom
Boehringer Ingelheim

Completed

Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

Hypertension
Boehringer Ingelheim

Completed

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Hypertension
Boryung Pharmaceutical Co., Ltd
Asan Medical Center; Chonnam National University Hospital; Seoul National University... and other collaborators

Completed

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension

Korea, Republic of
AstraZeneca

Completed

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Primary Hypertension

Romania
GlaxoSmithKline

Completed

Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]

Nausea and Vomiting, Chemotherapy-Induced

United States
Merck Sharp & Dohme LLC

Completed

Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)

Chemotherapy-induced Nausea and Vomiting (CINV)
Centro Cardiologico Monzino

Completed

Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure (CARNEBI)

Chronic Heart Failure

Italy
Azienda Sanitaria-Universitaria Integrata di Udine
University of Udine

Recruiting

Efficacy and Safety of Anakinra in Acute Respiratory Distress Syndrome (ESKA)

Acute Respiratory Distress Syndrome

Italy
Herlev and Gentofte Hospital

Not yet recruiting

The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis

Allergic Contact Dermatitis
Radboud University Medical Center
Dutch Cancer Society

Active, not recruiting

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial (AFFECT-2)

Multiple Myeloma

Netherlands
University of Manchester

Terminated

SCIL-1Ra in COVID-19 Feasibility & PK/PD (SCIL_COV19)

COVID-19

United Kingdom
Virginia Commonwealth University

Completed

Anakinra to Prevent Post-infarction Remodeling (VCU-ART)

ST Segment Elevation Acute Myocardial Infarction

United States
Rigshospitalet, Denmark

Withdrawn

IL-1RA, Acute Exercise, and Beta-cell Function (ANEX)

Type 2 Diabetes Mellitus

Denmark
Chinese Medical Association

Not yet recruiting

Effects of Heart Control at Different Stages in Patients of Septic Shock With Tachycardia

Septic Shock | Tachycardia
University of Hawaii
National Institute on Minority Health and Health Disparities (NIMHD)

Terminated

Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients

COVID-19

United States
Xiaoduo Fan

Terminated

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Schizophrenia | Schizo Affective Disorder | Treatment-resistant Schizophrenia

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) (TRAFIC)

HIV-1 Infection

United States, Puerto Rico
Yale University
National Institute of Mental Health (NIMH); National Institute of Neurological... and other collaborators

Completed

Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection (SEARCH018)

HIV Infections | Acute HIV Infection

Thailand
University of Chicago
Takeda

Completed

Effect of Azilsartan on Aldosterone in Postmenopausal Females

Hypertension

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Optimal Treatment for Kidney Disease in HIV Infected Adults

HIV Infections | Kidney Disease

United States
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers

Healthy
Columbia University
Novartis Pharmaceuticals

Terminated

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Diabetic Nephropathy | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Glomerulonephritis, Membranous | Hypertensive Nephrosclerosis | Proteinuric Kidney Disease | Glomerulopathy (Obesity-associated)

United States
AstraZeneca

Completed

Bioequivalence Study in Healthy Subjects

Hypertension

United Kingdom
Bristol-Myers Squibb
Sanofi

Completed

Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)

Atrial Fibrillation

Spain
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Long Term Effects of Enalapril and Losartan on Genetic Heart Disease

Myocardial Ischemia | Hypertrophic Cardiomyopathy | Left Ventricular Hypertrophy

United States
Sanofi

Completed

Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol (IREDIS)

Hypertension | Diabetes Mellitus Type 2

Turkey
Jennifer Holder-Murray
Berry Consultants

Recruiting

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

Perioperative Optimization

United States
University Hospital, Basel, Switzerland

Recruiting

IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes (Cephalira)

Inflammation | Metabolic Disease | Diabetes Mellitus Type 2 in Obese | Glucose Metabolism Disorders (Including Diabetes Mellitus)

Switzerland
Juno Therapeutics, a Subsidiary of Celgene

Completed

Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma (EVOLVE)

Multiple Myeloma

United States
Hellenic Institute for the Study of Sepsis

Active, not recruiting

Personalized Immunotherapy in Sepsis (ImmunoSep)

Sepsis

Greece, Germany, Netherlands, Romania, Switzerland
NYU Langone Health

Withdrawn

Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty

Arthrofibrosis

United States
Novartis

Completed

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

Hypertension | Congestive Heart Failure
University of Southern Denmark
Bristol-Myers Squibb

Completed

Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

Myocardial Infarction

Denmark
AstraZeneca
Takeda

Completed

DIabetic Retinopathy Candesartan Trials. (DIRECT)

Type 1 Diabetes
ANRS, Emerging Infectious Diseases
Sanofi

Completed

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C (Fibrosar)

Hepatitis C, Chronic

France
Boehringer Ingelheim

Completed

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Hypertension | Diabetic Nephropathies

Spain, Taiwan, Malaysia, Italy, Portugal, France, Czech Republic, Korea, Republic of, Russian Federation, Denmark, Germany, Slovakia, Ukraine
Novartis

Completed

Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)

Hypertension
Slovak Academy of Sciences

Unknown

Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker (ADIRAS)

Hypertension

Slovakia
AstraZeneca

Completed

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

Hypertension

United States
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension

Hypertension

United States, Puerto Rico
AstraZeneca
Takeda

Completed

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France (SISTOLA)

Heart Failure | Cohort Study

France
Takeda

Completed

Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.

Heart Failure

Germany
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Inherited Changes of Receptors Located on Blood Vessels

Cardiovascular Disease

United States

Search clinical trials for: Neurokinin-1 Receptor Antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations